"The fully enclosed Pavilion provides an immersive experience on the history, evolution, and future ofphotomedicine, including CLINUVEL’s development program with the novel drug SCENESSE®(afamelanotide) to treat vitiligo."
Ann: CLINUVEL Unveils Vitiligo Program for AAD 2025, page-6
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$9.81 |
Change
-0.020(0.20%) |
Mkt cap ! $491.7M | |||
| Open | High | Low | Value | Volume |
| $9.89 | $9.99 | $9.66 | $899.3K | 91.51K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10000 | $9.76 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $9.84 | 1739 | 2 |
View Market Depth
| Last trade - 16.10pm 16/06/2025 (20 minute delay) ? |
| CUV (ASX) Chart |